A virosomal malaria peptide vaccine elicits a long-lasting sporozoite-inhibitory antibody response in a phase 1a clinical trial (Q33308737)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | A virosomal malaria peptide vaccine elicits a long-lasting sporozoite-inhibitory antibody response in a phase 1a clinical trial |
scientific article |
Statements
1 reference
A virosomal malaria peptide vaccine elicits a long-lasting sporozoite-inhibitory antibody response in a phase 1a clinical trial (English)
1 reference
Robert W Sauerwein
1 reference
Blaise Genton
1 reference
Gerd Pluschke
1 reference
Dominique Mazier
1 reference
Shinji L Okitsu
1 reference
Nicole Westerfeld
1 reference
Marija Curcic
1 reference
Andreas R Kammer
1 reference
Markus S Mueller
1 reference
John A Robinson
1 reference
Rinaldo Zurbriggen
1 reference
5 December 2007
1 reference
5 December 2007
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference